Morgan Stanley’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.46K | Buy |
387
+33
| +9% | +$329 | ﹤0.01% | 7224 |
|
|
2025
Q4 | $2.95K | Sell |
354
-587
| -62% | -$5.92K | ﹤0.01% | 7171 |
|
|
2025
Q3 | $11.3K | Sell |
941
-359
| -28% | -$4.39K | ﹤0.01% | 6869 |
|
|
2025
Q2 | $11K | Sell |
1,300
-15,339
| -92% | -$156K | ﹤0.01% | 6829 |
|
|
2025
Q1 | $188K | Buy |
16,639
+6,851
| +70% | +$124K | ﹤0.01% | 5754 |
|
|
2024
Q4 | $200K | Buy |
9,788
+8,686
| +788% | +$253K | ﹤0.01% | 5786 |
|
|
2024
Q3 | $43.8K | Buy |
1,102
+32
| +3% | +$861 | ﹤0.01% | 6260 |
|
|
2024
Q2 | $18.8K | Sell |
1,070
-693
| -39% | -$11.7K | ﹤0.01% | 6485 |
|
|
2024
Q1 | $29.3K | Sell |
1,763
-3,530
| -67% | -$51.3K | ﹤0.01% | 6381 |
|
|
2023
Q4 | $100K | Buy |
5,293
+1,897
| +56% | +$35.6K | ﹤0.01% | 6161 |
|
|
2023
Q3 | $70.6K | Buy |
3,396
+2,193
| +182% | +$66.6K | ﹤0.01% | 6024 |
|
|
2023
Q2 | $65.7K | Buy |
1,203
+48
| +4% | +$1.48K | ﹤0.01% | 6111 |
|
|
2023
Q1 | $20.9K | Sell |
1,155
-157
| -12% | -$2.71K | ﹤0.01% | 6614 |
|
|
2022
Q4 | $13.3K | Sell |
1,312
-19
| -1% | -$203 | ﹤0.01% | 6838 |
|
|
2022
Q3 | $17K | Buy |
1,331
+5
| +0.4% | +$76 | ﹤0.01% | 6862 |
|
|
2022
Q2 | $17K | Buy |
1,326
+44
| +3% | +$1.16K | ﹤0.01% | 7051 |
|
|
2022
Q1 | $67K | Sell |
1,282
-270
| -17% | -$11.4K | ﹤0.01% | 6551 |
|
|
2021
Q4 | $70K | Sell |
1,552
-33
| -2% | -$1.77K | ﹤0.01% | 6639 |
|
|
2021
Q3 | $104K | Sell |
1,585
-6,450
| -80% | -$489K | ﹤0.01% | 6354 |
|
|
2021
Q2 | $805K | Sell |
8,035
-1,772
| -18% | -$183K | ﹤0.01% | 5209 |
|
|
2021
Q1 | $1.25M | Buy |
9,807
+2,810
| +40% | +$415K | ﹤0.01% | 4587 |
|
|
2020
Q4 | $777K | Buy |
6,997
+6,277
| +872% | +$703K | ﹤0.01% | 4801 |
|
|
2020
Q3 | $85K | Sell |
720
-272
| -27% | -$47.1K | ﹤0.01% | 5506 |
|
|
2020
Q2 | $213K | Buy |
992
+7
| +0.7% | +$1.65K | ﹤0.01% | 5048 |
|
|
2020
Q1 | $223K | Sell |
985
-2,437
| -71% | -$695K | ﹤0.01% | 4818 |
|
|
2019
Q4 | $919K | Buy |
3,422
+523
| +18% | +$132K | ﹤0.01% | 4592 |
|
|
2019
Q3 | $881K | Buy |
2,899
+1,290
| +80% | +$396K | ﹤0.01% | 4369 |
|
|
2019
Q2 | $534K | Buy |
1,609
+133
| +9% | +$67.5K | ﹤0.01% | 4578 |
|
|
2019
Q1 | $924K | Sell |
1,476
-731
| -33% | -$333K | ﹤0.01% | 4165 |
|
|
2018
Q4 | $548K | Buy |
2,207
+809
| +58% | +$322K | ﹤0.01% | 4731 |
|
|
2018
Q3 | $649K | Sell |
1,398
-392
| -22% | -$190K | ﹤0.01% | 4840 |
|
|
2018
Q2 | $971K | Sell |
1,790
-40
| -2% | -$24K | ﹤0.01% | 4655 |
|
|
2018
Q1 | $1.05M | Sell |
1,830
-95
| -5% | -$60K | ﹤0.01% | 4513 |
|
|
2017
Q4 | $1.23M | Buy |
1,925
+1,199
| +165% | +$845K | ﹤0.01% | 4406 |
|
|
2017
Q3 | $683K | Buy |
726
+181
| +33% | +$138K | ﹤0.01% | 4685 |
|
|
2017
Q2 | $476K | Sell |
545
-357
| -40% | -$292K | ﹤0.01% | 4828 |
|
|
2017
Q1 | $621K | Sell |
902
-1,915
| -68% | -$1.26M | ﹤0.01% | 4699 |
|
|
2016
Q4 | $2.03M | Buy |
2,817
+2,383
| +549% | +$1.65M | ﹤0.01% | 3918 |
|
|
2016
Q3 | $319K | Sell |
434
-44
| -9% | -$35.6K | ﹤0.01% | 4778 |
|
|
2016
Q2 | $398K | Sell |
478
-2,637
| -85% | -$2.45M | ﹤0.01% | 4566 |
|
|
2016
Q1 | $2.57M | Buy |
3,115
+2,708
| +665% | +$2.13M | ﹤0.01% | 3143 |
|
|
2015
Q4 | $458K | Sell |
407
-696
| -63% | -$810K | ﹤0.01% | 4599 |
|
|
2015
Q3 | $936K | Buy |
1,103
+176
| +19% | +$255K | ﹤0.01% | 4160 |
|
|
2015
Q2 | $1.64M | Buy |
927
+255
| +38% | +$324K | ﹤0.01% | 3799 |
|
|
2015
Q1 | $807K | Sell |
672
-283
| -30% | -$331K | ﹤0.01% | 4299 |
|
|
2014
Q4 | $1.08M | Sell |
955
-85
| -8% | -$87.2K | ﹤0.01% | 4094 |
|
|
2014
Q3 | $1.05M | Sell |
1,040
-868
| -45% | -$981K | ﹤0.01% | 3994 |
|
|
2014
Q2 | $2.52M | Buy |
1,908
+921
| +93% | +$1.11M | ﹤0.01% | 3298 |
|
|
2014
Q1 | $1.37M | Buy |
987
+333
| +51% | +$433K | ﹤0.01% | 3741 |
|
|
2013
Q4 | $751K | Sell |
654
-213
| -25% | -$294K | ﹤0.01% | 4153 |
|
|
2013
Q3 | $1.09M | Sell |
867
-151
| -15% | -$102K | ﹤0.01% | 3724 |
|
|
2013
Q2 | $405K | Buy |
+1,018
| New | +$432K | ﹤0.01% | 4409 |
|
Other funds holding RMTI
VCM
VFT
WANY
Morgan Stanley's RMTI Position: Q1 2026 in Review
Morgan Stanley increased its Rockwell Medical (RMTI) stake by 9.3% in Q1 2026, buying an estimated $329 and bringing the position to 387 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #7224.
Morgan Stanley first reported a position in RMTI in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.57M in Q1 2016. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- Morgan Stanley held 387 shares of Rockwell Medical worth $3.46K as of Q1 2026.
- Morgan Stanley bought 33 Rockwell Medical shares in Q1 2026, an estimated $329.
- Rockwell Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7224 holding.
- Morgan Stanley first reported a position in Rockwell Medical in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Rockwell Medical position peaked at $2.57M in Q1 2016.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.